| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.35B | 32.03B | 22.67B | 23.26B | 22.01B | 21.35B |
| Gross Profit | 26.35B | 27.10B | 21.19B | 20.91B | 20.35B | 20.90B |
| EBITDA | 2.40B | 4.68B | 3.76B | -3.37B | 2.57B | 4.69B |
| Net Income | 2.15B | 2.00B | 1.86B | -3.30B | 1.47B | 2.58B |
Balance Sheet | ||||||
| Total Assets | 1.80T | 1.81T | 1.81T | 1.76T | 1.89T | 1.81T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 226.39B | 243.10B | 165.70B | 248.75B | 186.75B |
| Total Debt | 106.67B | 77.18B | 118.03B | 133.95B | 126.69B | 295.63B |
| Total Liabilities | 1.73T | 1.73T | 1.73T | 1.68T | 1.81T | 1.73T |
| Stockholders Equity | 73.94B | 79.34B | 71.65B | 78.40B | 73.67B | 81.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.80B | 0.00 | -6.70B | 57.40B | -1.07B |
| Operating Cash Flow | 0.00 | 8.82B | 0.00 | -6.26B | 58.32B | 77.00M |
| Investing Cash Flow | 0.00 | -22.19B | 4.74B | 61.00B | 4.83B | -28.35B |
| Financing Cash Flow | 0.00 | -4.44B | 51.92B | -81.21B | -797.00M | -719.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥26.77B | 9.65 | ― | 3.50% | 1.03% | 12.15% | |
70 Outperform | ¥44.24B | 10.24 | ― | 3.28% | 17.02% | 10.99% | |
69 Neutral | ¥13.84B | 8.73 | ― | 3.30% | 20.18% | 20.57% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥28.96B | 14.07 | ― | 2.59% | 17.44% | 9.26% | |
59 Neutral | ¥17.13B | 14.62 | ― | 3.37% | 6.15% | -0.87% | |
58 Neutral | ¥45.44B | -1.87 | ― | 2.87% | 26.62% | -660.86% |